NASDAQ:IPGP

IPG Photonics stock (IPGP) steadies premarket after 35% surge on earnings, $100 million buyback

IPG Photonics shares were flat in premarket trading near $150 after a 35% surge Thursday, which set a 52-week high. The company reported fourth-quarter revenue up 17% to $274.5 million, but gross margin slipped to 36.1%. The board approved a $100 million share buyback. Raymond James downgraded the stock on valuation but raised its price target to $180.

13 February 2026

Earnings Reports·NASDAQ:IPGP·Share Buybacks·Stock Market

Why Coherent stock is jumping today as a unit sale closes and earnings loom

Coherent Corp shares rose 6.9% to $226.83 Monday ahead of its earnings report due Wednesday after market close. The move followed news that Bystronic finalized its purchase of Coherent’s Tools for Materials Processing unit. Morgan Stanley raised its price target to $190 but kept a neutral rating. Trading remained volatile as investors watched for updates on AI data center demand and debt repayment.

2 February 2026

Earnings Reports·NASDAQ:COHR·NASDAQ:IPGP·NASDAQ:LITE·Stock Market·Technology

Lumentum stock rebounds today after Monday slide as year-end trading stays thin

Lumentum shares rose 1.3% to $377.59 in midday trading Tuesday, recovering part of Monday’s 4.65% slide. Trading volume was about 800,000 shares, with the stock moving between $370 and $380.32. Optical-component peers were mixed, as Applied Optoelectronics gained and IPG Photonics slipped. Investors cited thin holiday liquidity and awaited U.S. economic data for direction.

30 December 2025

NASDAQ:AAOI·NASDAQ:COHR·NASDAQ:IPGP·NASDAQ:LASR·NASDAQ:LITE·Stock Market

Lumentum stock slides late as year-end tech pullback hits AI optics names

Lumentum shares dropped 4.6% to $372.61 in after-hours trading Monday, outpacing declines in other optical hardware stocks. The move followed a broader tech pullback, with the S&P 500 down 0.35% and Nasdaq off 0.50%. Investors are watching for signs the AI trade will regain momentum ahead of Fed minutes and jobless claims later this week.

30 December 2025

NASDAQ:CIEN·NASDAQ:COHR·NASDAQ:IPGP·NASDAQ:LITE·Stock Market

Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).